iPS PORTAL

iPS PORTAL

A company focused on stem cell research including iPS cells and regenerative medicine research.

HQ location
Kyoto, Japan
Launch date
Enterprise value
$9—14m
Recent deals
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
investor

€0.0

round
investor investor investor investor investor investor investor investor investor investor investor investor investor investor

€0.0

round
investor investor investor

€0.0

round

$15.1m

Late VC
Total Funding000k
Notes (0)
More about iPS PORTAL
Made with AI
Edit

iPS Portal is a specialized company offering professional outsourcing services in research and development (R&D), with a strong focus on regenerative medicine, technology, and education. The company serves a diverse range of clients including academic institutions, biotech firms, and pharmaceutical companies. Operating in the highly specialized market of regenerative medicine and advanced technology, iPS Portal provides tailored R&D solutions that help clients accelerate their research and development processes. The business model is service-based, generating revenue through contracts and partnerships for outsourced R&D projects. By leveraging cutting-edge technology and scientific expertise, iPS Portal enables its clients to achieve breakthroughs in medical and technological advancements.

Keywords: R&D outsourcing, regenerative medicine, biotechnology, pharmaceutical, academic research, technology solutions, scientific expertise, advanced technology, medical advancements, tailored solutions.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Investments by iPS PORTAL

Edit
iPS PORTAL
ACQUISITION by iPS PORTAL Sep 2014